Option Chain

AbCellera Biologics Inc

ABCLNASDAQ · USD

12.66USD+0.03 (+0.24%)

2210

AbCellera Biologics Inc (ABCL) Option Chain

As of September 18, 2026, AbCellera Biologics Inc is trading at $12.66, a +0.24% change from the previous close. The nearest expiration is Oct 16, 2026. Implied volatility is 89.2%. IV Rank is 15%.

Tracking the ABCL option chain helps you see every strike and expiry on AbCellera Biologics Inc in one view, so you can quickly identify the contracts that fit your thesis and your risk. AbCellera Biologics Inc's option chain lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of ABCL options activity at a glance. Use our scanner to monitor the ABCL option chain in real time and filter for the ABCL options trades that actually meet your criteria.

An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For ABCL stock options, the chain shows side-by-side call and put data, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading the ABCL option chain effectively means looking beyond the last price — implied volatility by strike, volume-to-open-interest ratios, and bid-ask spreads all tell you where ABCL stock options are being actively traded and where they are not.

AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in progress, or under contract with 36 partners. AbCellera Biologics Inc. has a research collaboration and license agreement with Eli Lilly and Company. The company was incorporated in 2012 and is headquartered in Vancouver, Canada.

Credit spreads, long calls, iron condors, calendar trades — every strategy starts with the same raw material: a clean, complete option chain. Our scanner pulls AbCellera Biologics Inc's full chain across every expiry, highlights the most liquid strikes, and lets you screen ABCL options by the metrics that matter, from IV skew to volume surges. Stop scrolling through endless rows of ABCL stock options — let the full option chain come to you, pre-filtered and ready to trade.

Stock Statistics

IndustryBiotechnology
SectorHealthcare
IV percentile9.92% Subdued
Market cap (M$)4,093
52 weeks high-4.17%
52 weeks low360.95%
Analyst recommendationStrong Buy
1.00
Target price$17.12
35.23% above the current stock price
Dividend—
Payout ratio—
Earnings date2026-11-05
P/E—
Future P/E—
EPS (ttm)-0.54
EPS growth next 5 years-18.92%

As of September 18, 2026

CALLs									PUTs
Prob. OTM %	Open Interest	Volume	Extrinsic Value	Intrinsic Value	Bid	Ask	Strike	Moneyness %	Bid	Ask	Intrinsic Value	Extrinsic Value	Volume	Open Interest	Prob. OTM %
32.37	740	2	0.44	1.66	1.60	2.60	11.00	-12.91	0.45	0.50	0.00	0.48	74	3,059	67.63
46.01	1,789	178	0.94	0.66	1.30	1.90	12.00	-4.99	0.15	1.00	0.00	0.58	12	914	54.00
59.03	2,864	115	1.10	0.00	0.95	1.25	13.00	+2.93	1.35	1.60	0.34	1.14	5	76	40.97
70.28	1,339	18	0.93	0.00	0.60	1.25	14.00	+10.85	1.45	2.20	1.34	0.49	0	5	29.72
79.26	1,932	117	0.65	0.00	—	0.65	15.00	+18.76	2.40	3.40	2.34	0.56	0	3	20.74

As of September 18, 2026

Browse all Option Chain tickers

Stock Statistics

Scan the full option chain in one place